Central and Systemic Inflammation in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of MT-4666
- Status
- COMPLETED
- Phase
- PHASE2
Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).
- Status
- UNKNOWN
- Phase
- NA
Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
- Status
- COMPLETED
- Phase
- N/A
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
- Status
- COMPLETED
- Phase
- N/A
Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Arterial Spin Labeling (ASL) MRI for Cognitive Decline
- Status
- COMPLETED
- Phase
- N/A
Effects of Exercise Training in Patients With Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
- Status
- WITHDRAWN
- Phase
- PHASE2
An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption
- Status
- COMPLETED
- Phase
- PHASE1
Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2